NFKB1 and major depressive disorder: Ketamine administration decreased the levels of IL-6, TNF-α, and IL-1β and suppressed the activation of NF-κB in depressed mice, suggesting pro-inflammatory inhibition plays an important role in depression treatment [34, 35].